Haematology 2018

Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T cell lymphoma

Chief investigator Professor Tim Illidge

Trial Sponsor:

University College London

UCL/17/0053

Trial Sponsor reference:

Merck Sharp & Dohme Limited

Trial funder(s):

MISP# 52167

Funder(s) reference:

TBC

Clinicaltrials.gov no: NCT03385226

EUDRACT no:

2017-000433-30

CTA no:

TBC